Back to Newsroom
Back to Newsroom

CBD Life Sciences, Inc. (CBDL) Signs MOU With Large Mushroom Supplement Company

Thursday, 01 August 2024 08:00 AM

CBD Life Sciences, Inc.

SCOTTSDALE, AZ / ACCESSWIRE / August 1, 2024 / CBD Life Sciences Inc. (OTC PINK:CBDL), including its wholly-owned subsidiary, The CBD Vault Inc., a leading innovator in the CBD industry, has announced that it's signed a MOU (Memorandum of understanding) with a mushroom supplement company. This company will work hand in hand with our vision as were able to expand our revenue opportunities into not only the CBD space but the mushroom space as well!

Adaptogenic mushrooms are mushrooms that may help the body respond to stress, anxiety, fatigue, and overall well-being. They are different than "magic" mushrooms and do not effect the mind instead they help with healing of the overall body. Millions of people across the country use mushrooms supplements every day for their vast benefits to everyday life.

The CBD Vault Inc. is a wholly owned subsidiary of CBD Life Sciences Inc. The CBD Vault has developed and is retailing/wholesale a full line of cannabidiol based & organic products including, Delta 8 & 10 Gummy's, Full Spectrum Tinctures & Gummy's, Pain Cream, Roll-on's, Salve, Full Pet Line, Pre-Rolls, Full Line of Spa Products, Sleep & Anxiety Edibles. The CBD Vault's products can be viewed and purchased on the Company's website www.thecbdvault.com.

Follow our social media for the latest updates!

X: https://www.x.com/CBDL_StockOTC

Instagram: https://www.instagram.com/cbd.vault

IR Contact: [email protected]

Forward-Looking Statements
Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements. Actual results may differ materially from those described in forward-looking statements and are subject to risks and uncertainties. See CBD Life Sciences, Inc's, Inc.'s filings with OTC Markets, which may identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements.

Safe Harbor Statement
This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements.

Contact Information
Lisa Nelson
CEO
[email protected]
4802091720

SOURCE: CBD Life Sciences Inc.

Topic:
Company Update
Back to newsroom
Back to Newsroom

Contact Us Today


If you have questions or want to learn more about our products, our team’s here to help!

Share by: